144 related articles for article (PubMed ID: 32432739)
1. TPM4 aggravates the malignant progression of hepatocellular carcinoma through negatively regulating SUSD2.
Sheng ZG; Chen MH
Eur Rev Med Pharmacol Sci; 2020 May; 24(9):4756-4765. PubMed ID: 32432739
[TBL] [Abstract][Full Text] [Related]
2. MIIP inhibits malignant progression of hepatocellular carcinoma through regulating AKT.
Fang J; Chen YL; Yao HB; Peng SS; Yang P; Ding ZY
Eur Rev Med Pharmacol Sci; 2020 Mar; 24(5):2335-2346. PubMed ID: 32196585
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-30a-3p inhibits malignant progression of hepatocellular carcinoma through regulating IGF1.
Wei YY; Ren TL
Eur Rev Med Pharmacol Sci; 2020 Dec; 24(23):12144-12152. PubMed ID: 33336732
[TBL] [Abstract][Full Text] [Related]
4. Circ_0000515 drives the progression of hepatocellular carcinoma by regulating MAPK10.
Li H; Li CM; Yuan R; Wang HB; Wei J
Eur Rev Med Pharmacol Sci; 2020 Jun; 24(11):6014-6022. PubMed ID: 32572915
[TBL] [Abstract][Full Text] [Related]
5. MiRNA-1179 suppresses the metastasis of hepatocellular carcinoma by interacting with ZEB2.
Gao HB; Gao FZ; Chen XF
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5149-5157. PubMed ID: 31298368
[TBL] [Abstract][Full Text] [Related]
6. FBXO17 promotes malignant progression of hepatocellular carcinoma by activating wnt/β-catenin pathway.
Liu FH; Cui YP; He YK; Shu RH
Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8265-8273. PubMed ID: 31646557
[TBL] [Abstract][Full Text] [Related]
7. LncRNA MT1JP inhibits the malignant progression of hepatocellular carcinoma through regulating AKT.
Wu JH; Xu K; Liu JH; Du LL; Li XS; Su YM; Liu JC
Eur Rev Med Pharmacol Sci; 2020 Jun; 24(12):6647-6656. PubMed ID: 32633354
[TBL] [Abstract][Full Text] [Related]
8. LncRNA TP73-AS1 promotes malignant progression of hepatoma by regulating microRNA-103.
Ma CX; Gao WC; Tian L
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(11):4713-4722. PubMed ID: 31210297
[TBL] [Abstract][Full Text] [Related]
9. Hepatocellular carcinoma progression is protected by miRNA-34c-5p by regulating FAM83A.
Yu WS; Wang ZG; Guo RP; Lin ZQ; Ye ZW; Lu CL
Eur Rev Med Pharmacol Sci; 2020 Jun; 24(11):6046-6054. PubMed ID: 32572919
[TBL] [Abstract][Full Text] [Related]
10. [LncRNA HULC promots HCC growth by downregulating miR-29].
Zhu LR; Feng JL; Liu XJ; Wang JM
Zhonghua Zhong Liu Za Zhi; 2019 Sep; 41(9):659-666. PubMed ID: 31550855
[No Abstract] [Full Text] [Related]
11. MiR-5692a promotes the invasion and metastasis of hepatocellular carcinoma via MMP9.
Sun SJ; Wang N; Sun ZW; Chen J; Cui HW
Eur Rev Med Pharmacol Sci; 2018 Aug; 22(15):4869-4878. PubMed ID: 30070322
[TBL] [Abstract][Full Text] [Related]
12. TRIM66 promotes malignant progression of hepatocellular carcinoma by inhibiting E-cadherin expression through the EMT pathway.
Zhang HG; Pan YW; Feng J; Zeng CT; Zhao XQ; Liang B; Zhang WW
Eur Rev Med Pharmacol Sci; 2019 Mar; 23(5):2003-2012. PubMed ID: 30915743
[TBL] [Abstract][Full Text] [Related]
13. LncRNA H19 promotes the development of hepatitis B related hepatocellular carcinoma through regulating microRNA-22 via EMT pathway.
Li L; Han T; Liu K; Lei CG; Wang ZC; Shi GJ
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5392-5401. PubMed ID: 31298392
[TBL] [Abstract][Full Text] [Related]
14. STYXL1 promotes malignant progression of hepatocellular carcinoma via downregulating CELF2 through the PI3K/Akt pathway.
Wu JZ; Jiang N; Lin JM; Liu X
Eur Rev Med Pharmacol Sci; 2020 Mar; 24(6):2977-2985. PubMed ID: 32271415
[TBL] [Abstract][Full Text] [Related]
15. Circular RNA circGFRA1 promotes angiogenesis, cell proliferation and migration of hepatocellular carcinoma by combining with miR-149.
Yu YX; Ge TW; Zhang P
Eur Rev Med Pharmacol Sci; 2020 Nov; 24(21):11058-11064. PubMed ID: 33215421
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-328-3p inhibits malignant progression of hepatocellular carcinoma by regulating MMP-9 level.
Li JZ; Li J; Liu BZ
Eur Rev Med Pharmacol Sci; 2019 Nov; 23(21):9331-9340. PubMed ID: 31773692
[TBL] [Abstract][Full Text] [Related]
17. LncRNA TATDN1 induces the progression of hepatocellular carcinoma via targeting miRNA-6089.
Shen C; Xu Y; Lu TF; Zhang JJ; Qian YB; Xu N
Eur Rev Med Pharmacol Sci; 2019 Aug; 23(15):6459-6466. PubMed ID: 31378885
[TBL] [Abstract][Full Text] [Related]
18. Knockdown of LncRNA ANRIL suppresses cell proliferation, metastasis, and invasion via regulating miR-122-5p expression in hepatocellular carcinoma.
Ma J; Li T; Han X; Yuan H
J Cancer Res Clin Oncol; 2018 Feb; 144(2):205-214. PubMed ID: 29127494
[TBL] [Abstract][Full Text] [Related]
19. The competing endogenous circular RNA ADAMTS14 suppressed hepatocellular carcinoma progression through regulating microRNA-572/regulator of calcineurin 1.
Song C; Li D; Liu H; Sun H; Liu Z; Zhang L; Hu Y
J Cell Physiol; 2019 Mar; 234(3):2460-2470. PubMed ID: 30317540
[TBL] [Abstract][Full Text] [Related]
20. CircRNA_0000502 promotes hepatocellular carcinoma metastasis and inhibits apoptosis through targeting microRNA-124.
Zhang S; Liu Y; Liu Z; Zhang Y; Chen G; Li K; Tang K
J BUON; 2019; 24(6):2402-2410. PubMed ID: 31983112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
